Novo Nordisk A/S logo NVO - Novo Nordisk A/S

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 24
HOLD 11
SELL 3
STRONG
SELL
0
| PRICE TARGET: $55.00 DETAILS
HIGH: $70.00
LOW: $47.00
MEDIAN: $51.50
CONSENSUS: $55.00
DOWNSIDE: 11.76%

About Novo Nordisk A/S (https://www.novonordisk.com)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Key Executives

NAME TITLE DOB SALARY
Karsten Munk Knudsen Executive VP, CFO & Member of the Management Board 1971 $2,703,238 DKK
Henrik Ehlers Wulff Executive VP of CMC & Product Supply and Member of the Management Board 1970 $2,027,429 DKK
Martin Holst Lange EVP of R&D, Chief Scientific Officer and Member of the Management Board 1970 $1,917,413 DKK
David S. Moore Executive VP of US Operations & Member of Management Board 1974
Emil Kongshøj Larsen EVP of International Operations & Member of Management Board 1975
Jacob Martin Wiborg Rode Head of Investor Relations
John F. Kuckelman Group General Counsel
Ludovic Helfgott Executive VP of Product & Portfolio Strategy and Member of Management Board 1974
Maziar Mike Doustdar President, Chief Executive Officer & Member of the Management Board 1970
Peter Hugreffe Ankersen Corporate Vice President
Tania Sabroe EVP of People, Organisation and Corporate Affairs & Member of Management Board 1977
Thilde Hummel Bogebjerg Executive VP of Quality, IT & Environmental Affairs and Member of Management Board